- Home
- SLNO vs CLDX Comparison
SLNO vs CLDX Comparison
Compare SLNO & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | CLDX |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SLNO | CLDX |
|---|---|---|
| Price | $52.77 | $34.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $90.13 | $44.50 |
| AVG Volume (30 Days) | ★ 6.0M | 1.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.90 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | $1,450,788.00 | ★ $12,743,000.00 |
| Revenue This Year | $150.46 | $111.39 |
| Revenue Next Year | $50.37 | $235.85 |
| P/E Ratio | $134.78 | ★ N/A |
| Revenue Growth | ★ 138.82 | 87.78 |
| 52 Week Low | $29.43 | $17.87 |
| 52 Week High | $89.12 | $34.52 |
Technical Indicators
Market Signals| Indicator | SLNO | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 77.61 | 66.82 |
| Support Level | $48.91 | $24.70 |
| Resistance Level | $55.47 | N/A |
| Average True Range (ATR) | 1.08 | 1.45 |
| MACD | 1.15 | 0.16 |
| Stochastic Oscillator | 99.91 | 90.62 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.